The next meeting of the AOTMiT Transparency Council is taking place on May 8.
The agenda includes:
Preparation of a position paper on the evaluation of the legitimacy of the qualification of the health care service "Pediatric emergency care" as a guaranteed benefit of hospital treatment.
Preparation of a position paper on the appropriateness of issuing reimbursement approvals for the drug Welireg (belzutifan) for the indications von Hippel-Lindau syndrome (VHL); von Hippel-Lindau syndrome (VHL) for high-risk radiation therapy and surgical treat...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
